6C: Biomaterials for ImmunoEngineering 2

Date: Friday, March 27, 2026
Time: 1:30 PM to 3:30 PM

Description

Over the past decade the focus of many bioengineers and clinicians has been shifting towards "immune engineering" approaches that include but are not limited to engineered biomaterials for vaccines, immunotherapy (immune modulation), cell and gene therapy, immune microenvironment engineering, and systems immunology. These research areas embrace a comprehensive list of translational immunology-associated problems including chronic infections, autoimmune diseases, aggressive cancers, allergies, etc. The purpose of the Immune Engineering SIG is to bring together emerging ideas and provide a venue for professional interaction to a large number of academic and industrial research groups and scientists working in these areas.

1:30 PM. 293. Biomaterial Assisted Lung-Lymphatic Assembly Recapitulates Influenza Infection.Eshant Bhatia, PhD1, Rachel Ringquist, Ph.D1, Krishnendu Roy, Ph.D.2, Ankur Singh, Dr.1 1Georgia Institute of Technology, 2Vanderbilt University
2:00 PM. 295. Adjuvanted Nanomaterials Reveal the Influence of Dendritic Cell Tissue Residency on Antitumor Immunity.Samuel Lucas1, Alexander Heiler1, Guanzhen He1, Margaret Manspeaker, Ph.D.1, Susan Thomas, Ph.D.1 1Georgia Institute of Technology
2:15 PM. 296. Local Delivery of Anti-Cytokine Active Immunotherapy to Treat Pulmonary Fibrosis.Maria Kulapurathazhe1, Shamitha Shetty1, Pablo Cordero1, Joel Collier, PhD1 1Duke University
2:45 PM. 298. A Heparin-containing Hydrogel System for Localized and Sustained Release of IL-10 for Rotator Cuff Injuries.Jiahui Mao, B.S., M.S.1, Johnna Temenoff2 1Georgia Institute of Technology & Emory University, 2Georgia Institute of Technology
3:15 PM. 300. Examining the role of aging and biological sex on lymph node biomechanics.Vedanth Sriram, B.S., M.S.1, Katharina Maisel, PhD2, Rebecca Lu1, Adedamola owolabi1, Calvin Witt1 1University of Maryland, College Park, 2University of Maryland
Defining the Epigenetic Landscape of Tonsil and PBMC-derived Synthetic Human Immune Organoids.Ishita Jain, PhD1, Andrés García, PhD2, Ankur Singh, Dr.2, Zhe Zhong2, Christopher Scharer, Dr.2 1Stanford University, 2Georgia Institute of Technology

Description

1:30 PM. 293. Biomaterial Assisted Lung-Lymphatic Assembly Recapitulates Influenza Infection.Eshant Bhatia, PhD1, Rachel Ringquist, Ph.D1, Krishnendu Roy, Ph.D.2, Ankur Singh, Dr.1 1Georgia Institute of Technology, 2Vanderbilt University

2:00 PM. 295. Adjuvanted Nanomaterials Reveal the Influence of Dendritic Cell Tissue Residency on Antitumor Immunity.Samuel Lucas1, Alexander Heiler1, Guanzhen He1, Margaret Manspeaker, Ph.D.1, Susan Thomas, Ph.D.1 1Georgia Institute of Technology

2:15 PM. 296. Local Delivery of Anti-Cytokine Active Immunotherapy to Treat Pulmonary Fibrosis.Maria Kulapurathazhe1, Shamitha Shetty1, Pablo Cordero1, Joel Collier, PhD1 1Duke University

2:45 PM. 298. A Heparin-containing Hydrogel System for Localized and Sustained Release of IL-10 for Rotator Cuff Injuries.Jiahui Mao, B.S., M.S.1, Johnna Temenoff2 1Georgia Institute of Technology & Emory University, 2Georgia Institute of Technology

3:15 PM. 300. Examining the role of aging and biological sex on lymph node biomechanics.Vedanth Sriram, B.S., M.S.1, Katharina Maisel, PhD2, Rebecca Lu1, Adedamola owolabi1, Calvin Witt1 1University of Maryland, College Park, 2University of Maryland

Defining the Epigenetic Landscape of Tonsil and PBMC-derived Synthetic Human Immune Organoids.Ishita Jain, PhD1, Andrés García, PhD2, Ankur Singh, Dr.2, Zhe Zhong2, Christopher Scharer, Dr.2 1Stanford University, 2Georgia Institute of Technology